Introduction

The immune system is the body's natural defense mechanism. It is made up of millions of specialized cells, including white blood cells, that constantly patrol the bloodstream to fight infections, detect abnormal cells, and keep the body healthy. In children, especially newborns and infants, this system is still developing and can be harder to assess using routine tests alone.

An Immune Cell Tracking System is a medical technology that identifies, counts, and monitors immune cells in the body. It can detect how many immune cells are present, what types they are, how they are behaving, and whether they are reacting to an infection or a disease process. This information helps clinicians make faster, more accurate medical decisions.

As medical technology has advanced, immune cell tracking has moved from large laboratory machines to compact, portable, and even wearable devices that can be used at the bedside, in clinics, and in resource-limited settings around the world.

Purpose and Where It Is Used

The primary purpose of an immune cell tracking system is to give clinicians accurate, timely information about a person's immune status. In pediatric medicine, this is especially valuable because:

• Newborns and premature babies have immature immune systems that are difficult to assess with standard tests.
• Children with cancer, autoimmune conditions, or transplanted organs require close monitoring of their immune cells over time.
• Early detection of infections like sepsis (a life-threatening blood infection) can save lives when identified quickly.
• Immune therapies such as CAR T-cell therapy require ongoing tracking to check if modified immune cells are working correctly in the body.

Where These Devices Are Used

Types of Immune Cell Tracking Systems

Several distinct technologies are used to track immune cells. Each works differently and is suited to specific clinical situations.

1. Flow Cytometry Systems

Flow cytometry is the most widely used method for immune cell tracking in clinical laboratories worldwide. A blood sample is passed through a machine where individual cells are hit by laser beams. Each cell scatters the light in a unique way depending on its size, shape, and surface markers. This allows the machine to identify and count thousands of cells per second.

• Can identify specific cell types: T cells, B cells, natural killer (NK) cells, neutrophils, and more.
• Used routinely in diagnosing leukemia, lymphoma, and immune deficiency diseases in children.
• Fluorescence-Activated Cell Sorting (FACS) is a specialized version that physically separates cells based on their characteristics.
• Spectral flow cytometry is a newer, more advanced form that can measure more cell markers at once, giving richer information.

2. Point-of-Care Microfluidic Devices

These are compact, bedside devices that analyze very small blood volumes - sometimes as little as a single drop. They use tiny channels (microfluidics) to guide cells through sensors that measure immune activity in real time.

• BLIPI (BiophysicaL Immune Profiling for Infants), developed through a collaboration between MIT and KK Women's and Children's Hospital in Singapore, is a notable example designed specifically for newborns. It uses one drop of blood and provides results within 15 minutes.
• Suitable for use in NICUs, rural hospitals, and resource-limited settings where laboratory infrastructure is not available.
• Measures immune cell size and flexibility (biophysical properties) as markers of infection or inflammation.

3. Wearable Continuous Monitoring Devices

These devices are worn on the skin and continuously track circulating immune cells without drawing blood. The most advanced example currently is CircTrek, developed by MIT researchers, which uses a focused laser beam directed at blood vessels beneath the skin. Cells are first labeled with fluorescent dyes or genetically modified to be detectable. The device reads the fluorescent signal as labeled cells pass under the sensor.

• Approximately the size of a smartwatch (about 42 mm x 35 mm).
• Contains a Wi-Fi module that can transmit data to a healthcare provider in real time.
• Especially useful for monitoring patients undergoing CAR T-cell therapy at home.
• Currently in the research and testing phase and not yet in widespread clinical use.

4. In Vivo Flow Cytometry (IVFC)

This technique monitors immune cells directly inside living tissue using high-powered laser microscopy. It provides continuous real-time data on circulating cells but currently requires large equipment and the person must remain in the facility for extended periods. It is primarily used in research settings.

5. Magnetic Resonance Imaging (MRI)-Based Cell Tracking

Immune cells are labeled with special iron-based contrast agents and then tracked using MRI scans. This method allows clinicians to visualize where immune cells travel inside the body - for example, detecting whether T-cells are accumulating at a tumor site or in a transplanted organ. It is non-invasive and does not use radiation.

User Guide: How Immune Cell Tracking Systems Are Used

The steps below describe the general process for the most commonly used type: laboratory-based flow cytometry. Point-of-care and wearable devices follow similar principles but vary by manufacturer and technology. Always follow the specific instructions provided by the device manufacturer.

Standard Flow Cytometry: Step-by-Step

For Point-of-Care Devices (e.g., Bedside Microfluidic Systems)

1. Apply the small blood sample (as specified by the device - often one drop) to the device's test cartridge or chip.
2. Insert the cartridge into the device according to manufacturer instructions.
3. Wait for the analysis period (typically 10-20 minutes).
4. Read the displayed result on the device screen or connected monitor.
5. Record results and report to the clinical team for interpretation.

Precautions and Important Safety Points

Sample Handling Precautions

• Blood samples must be labeled immediately after collection with the patient's unique identifier and date/time of collection. Mislabeling is a critical error.
• Samples stored at the wrong temperature (above 37 degrees Celsius or frozen) will show significantly altered immune cell counts and lead to incorrect results.
• Do not process samples beyond the manufacturer's stated stability window - immune cell populations change over time once outside the body.
• Handle all blood samples as potentially infectious. Use appropriate personal protective equipment (gloves, eye protection) at all times.

Device Operation Precautions

• Calibrate flow cytometers and other instruments according to the manufacturer's schedule and using approved calibration beads or controls. Run quality control samples before each batch of patient samples.
• Never use a device that shows an error message or has failed its quality control checks until the issue has been resolved.
• Keep laser components in flow cytometers shielded at all times. Laser beams used in these instruments can cause serious eye injury.
• Fluorescent reagents and dyes used in immune cell staining may be sensitive to light. Keep them protected from direct light sources.
• Do not use expired reagents or antibody kits. Expired materials can produce false results.

For Wearable Devices

• Wearable immune cell tracking devices use low-power laser beams directed through the skin. Studies have shown the temperature increase is minimal and below tissue-damaging levels, but devices should be positioned and used strictly as instructed.
• Cell labeling processes (using fluorescent dyes or genetic modification) must be performed in appropriate medical settings and only with approved, human-compatible labeling agents.
• Continuous monitoring data should be reviewed by a qualified clinician. A change in readings should prompt clinical review, not independent action.

For Newborns and Premature Infants

Interpreting Results in Children

• Normal immune cell ranges in children differ significantly by age. Newborns have very different reference values compared to school-age children and adolescents. Always use age-appropriate reference ranges when interpreting results.
• A single abnormal result does not confirm a diagnosis. Results must be interpreted together with clinical signs, symptoms, and other investigations.
• Medications such as corticosteroids, immunosuppressants, and chemotherapy agents significantly affect immune cell counts and must be considered when interpreting results.

Frequently Asked Questions

How to Keep the Device Safe and Functioning Correctly

Proper maintenance of immune cell tracking systems ensures reliable results and extends the life of the equipment.

Routine Maintenance

• Follow the manufacturer's preventive maintenance schedule strictly. This typically includes daily, weekly, and monthly checks depending on the device.
• Clean the fluidics system of flow cytometers regularly using manufacturer-approved cleaning solutions to prevent blockages and contamination between samples.
• Calibrate the device using standardized beads or controls every day before patient testing begins. Document all calibration results.
• Update device software as recommended by the manufacturer to maintain performance and security.

Storage

• Store reagents, antibody kits, and fluorescent dyes at the temperature specified on the label - most require refrigeration between 2 and 8 degrees Celsius.
• Do not freeze liquid antibody reagents unless specifically instructed by the manufacturer.
• Keep light-sensitive reagents protected from light exposure at all times.
• Store the device itself in a clean, dry, dust-free environment away from direct sunlight and temperature extremes.

Quality Control

• Run commercial quality control (QC) samples with every batch of patient samples. If QC values fall outside the acceptable range, do not report patient results until the problem is identified and corrected.
• Maintain a log of all QC results, calibration checks, and maintenance activities. This is required by accreditation standards in most countries.
• Participate in external quality assessment (EQA) or proficiency testing programmes if the device is used in a clinical laboratory. These programmes compare results across laboratories and ensure accuracy.

Handling Faults and Errors

• If the device displays an error code, consult the manufacturer's troubleshooting guide before attempting to use it further.
• Do not attempt to repair internal laser or optical components without factory-authorized training.
• Report recurring faults to a biomedical engineer or the manufacturer's service team promptly.

Data Security

• All immune cell tracking data linked to patient identities must be stored securely and in compliance with applicable patient privacy and data protection regulations in your region.
• Use unique patient identifiers on samples and results. Assign barcodes where possible to reduce transcription errors.
• Ensure software data is backed up regularly. Device data loss can have clinical consequences.

Additional Clinical Considerations

Age-Specific Reference Ranges in Children

One of the most important aspects of immune cell tracking in pediatric care is using the correct reference ranges. Immune cell populations change dramatically from birth through adolescence:

Medications That Affect Results

Several medications commonly used in children significantly alter immune cell counts and must be noted when ordering or interpreting tests:

• Corticosteroids (e.g., prednisolone) - increase neutrophil count, decrease lymphocyte count
• Chemotherapy agents - reduce all cell lines including immune cells
• Immunosuppressants (used after organ transplants) - deliberately reduce T-cell activity
• Some antibiotics and antiviral medications

Conditions Monitored Using Immune Cell Tracking

• Sepsis and severe infections in newborns and children
• Necrotizing enterocolitis (NEC) - a serious intestinal condition in premature infants
• Acute lymphoblastic leukemia (ALL) and other blood cancers - immune tracking is used to monitor treatment response and detect residual disease
• Primary immunodeficiency disorders - conditions where part of the immune system is absent or not working correctly
• HIV and other viral infections affecting immune cells
• Solid organ and bone marrow transplant monitoring
• Autoimmune diseases such as juvenile idiopathic arthritis and lupus

Future Developments

Research in immune cell tracking is advancing rapidly. Miniaturized bedside devices, wearable continuous monitors, and artificial intelligence-assisted analysis tools are expected to become more widely available in the coming years. These developments aim to make immune monitoring faster, less invasive, and accessible to more clinical settings globally, including those with limited resources.